HIGHLIGHTS
- who: Laureen P. Helweg and collaborators from the Department of Cell Biology, University of Bielefeld, Universitu00e4tsstrasse, Bielefeld, Germany have published the paper: Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy, in the Journal: (JOURNAL)
- what: The authors assessed the signaling of NF-u03baB and MYC with potential therapeutic applications in primary cancer stem_cells (CSCs) isolated from GBM. As a basis for new therapeutic strategies, the authors show that pharmacologic inhibition of NF-u03baB by ammonium pyrrolidine dithiocarbamate (PDTC) or inhibition of MYC/Myc-associated 3 of 24 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.